Apr 15
50 Hour, 500 MCQ Comprehensive Step 2/3 Review (June 1-12, 2026)
In this podcast, I discuss the upcoming 50 hour, 500 multiple choice question integrated review taking place in June of this year for Step 2/3 (and also Level 2/3). I’ll be teaching the entire course over zoom starting at 5.45 pm EST for all course days. Between all the teaching ... Show More
4m 29s
Sep 2024
Episode 115: AML Series, Pt. 1 - CHIP, CCUS, ICUS, oh my!
<p>This week, we kick off a new series focusing on myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). In this first episode, we discuss the alphabet soup of premalignant hematologic conditions including CHIP, CCUS, and ICUS, before moving onto MDS and AML in future ... Show More
35m 14s
Sep 2023
Episode 073: Management of Early Stage Diffuse Large B-Cell Lymphoma (DLBCL)
<p class="" style="white-space:pre-wrap;">This week, we continue our conversation about DLBCL, this time focusing our attention on the management of early stage disease. </p><p class="" style="white-space:pre-wrap;">If you have not done so, we highly recommend you listen to our ... Show More
29m 17s
Nov 2022
Episode 036: Hemophilia 101, Pt 1
<p class="" style="white-space:pre-wrap;">In this episode, we break down the initial approach to the evaluation of a patient with a suspected bleeding disorder, particularly in regards to hemophilia, including standardized bleeding assessment tools, the basics of the coagulation ... Show More
29m 16s
May 2025
Episode 136: Follicular Lymphoma Series, Pt. 1 - Introduction
<p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">This week, we kick off a new series, this time focusing on follicular lymphoma! This series will build on a lot of fundamentals that we discussed in our prior series. In this first episode, we start with an ... Show More
25m 58s
Oct 2023
Episode 077: Management of relapsed diffuse large B-cell lymphoma (DLBCL) - part 1
<p class="" style="white-space:pre-wrap;">In our last episode, we discussed our approach to primary refractory DLBCL. This week, we start our conversation about relapsed DLBCL! This is an important and complex discussion, so we have split it into two episodes to help you follow a ... Show More
26m 46s
Oct 2023
Episode 076: Management of primary refractory diffuse large B-cell lymphoma (DLBCL)
<p class="" style="white-space:pre-wrap;">This week, we pick up on our discussion about management of DLBCL, focusing on the primary refractory setting. A big part of this discussion is the role of CAR-T therapy. If you have not done so already, we highly recommend you check out ... Show More
35m 55s
Sep 2024
Episode 116: AML Series, Pt. 2 - MDS/AML Diagnosis and Risk Stratification
<p>In this week’s episode, we discuss the diagnostic criteria and risk stratification for myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), building on our discussion from last week. Also, if you have not done so, please do check out our hemepath series to ensure y ... Show More
31m 56s
This is one of my highest yield rapid review podcasts. In this episode, I discuss a lot of concepts relating to multi systems processes and disorders. I take one disorder and make so many common exam integrations while paying attention to pathophysiology. Please listen to this ahead of your exam. It will clarify so many … Continue reading DIP Ep 595: USMLE S ... Show More
<p class="" style="white-space:pre-wrap;">In today’s episode, we discuss how to approach AML treatment for patients who are unfit for intensive therapy.</p><p class="" style="white-space:pre-wrap;">Episode contents: </p><p class="" style="white-space:pre-wrap;">- How do we assess ... Show More
<p>In Part 3 of our Heme Path series, we break down the basics of immunohistochemistry (IHC)</p><p>Episode contents: </p><p>- What is immunohistochemistry? </p><p>- What are the pros and cons? </p><p>- How do we use this clinically? </p><p>****Have some time and want to make some ... Show More
